Literature DB >> 28763297

Adiponectin and leptin as first trimester markers for gestational diabetes mellitus: a cohort study.

Ida Näslund Thagaard1, Lone Krebs1, Jens-Christian Holm1, Theis Lange1, Torben Larsen1, Michael Christiansen1.   

Abstract

BACKGROUND: Gestational diabetes mellitus (GDM) is increasing partly due to the obesity epidemic. Adipocytokines have thus been suggested as first trimester screening markers for GDM. In this study we explore the associations between body mass index (BMI) and serum concentrations of adiponectin, leptin, and the adiponectin/leptin ratio. Furthermore, we investigate whether these markers can improve the ability to screen for GDM in the first trimester.
METHODS: A cohort study in which serum adiponectin and leptin were measured between gestational weeks 6+0 and 14+0 in 2590 pregnant women, categorized into normal weight, moderately obese, or severely obese.
RESULTS: Lower concentrations of adiponectin were associated with GDM in all BMI groups; the association was more pronounced in BMI<35 kg/m2 (p=0.30 for interaction). Leptin was inversely associated with GDM in severely obese (p=0.033), but showed no association in women with BMI<35 kg/m2. The adiponectin/leptin ratio was associated with GDM in women with BMI<35 kg/m2 but not in severely obese women (p=0.79). In regard to predicting GDM, maternal characteristics combined with adiponectin alone, adiponcetin and leptin, and adiponcetin/leptin ratio had the strongest associations in women with BMI<35 kg/m2. These models had a detection rate of 77.3%-80.3% when the false positive rate was fixed at 25%.
CONCLUSIONS: Low adiponectin measured in the first trimester is associated with the development of GDM; higher BMI was associated with lower performance of adiponectin, though this was insignificant. Leptin had an inverse relationship with GDM in severely obese women and did not improve the ability to predict GDM.

Entities:  

Keywords:  adiponectin; body mass index; first trimester screeing; gestational diabetes mellitus; leptin; obesity; pregnancy trimester

Mesh:

Substances:

Year:  2017        PMID: 28763297     DOI: 10.1515/cclm-2017-0427

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  15 in total

1.  Roles of Inflammation and Depression in the Development of Gestational Diabetes.

Authors:  Thalia K Robakis; Linn Aasly; Katherine Ellie Williams; Claire Clark; Natalie Rasgon
Journal:  Curr Behav Neurosci Rep       Date:  2017-10-28

Review 2.  Implications of Lipids in Neonatal Body Weight and Fat Mass in Gestational Diabetic Mothers and Non-Diabetic Controls.

Authors:  Emilio Herrera; Henar Ortega-Senovilla
Journal:  Curr Diab Rep       Date:  2018-02-05       Impact factor: 4.810

3.  Adipokine levels in overweight women with early-onset gestational diabetes mellitus.

Authors:  T F Lobo; M R Torloni; R Mattar; M U Nakamura; S M Alexandre; S Daher
Journal:  J Endocrinol Invest       Date:  2018-04-25       Impact factor: 4.256

Review 4.  Controversies in Screening and Diagnostic Criteria for Gestational Diabetes in Early and Late Pregnancy.

Authors:  Evelyn A Huhn; Simona W Rossi; Irene Hoesli; Christian S Göbl
Journal:  Front Endocrinol (Lausanne)       Date:  2018-11-27       Impact factor: 5.555

5.  Sexually Dimorphic Associations between Maternal Factors and Human Milk Hormonal Concentrations.

Authors:  Laura Galante; Hanna Lagström; Mark H Vickers; Clare M Reynolds; Samuli Rautava; Amber M Milan; David Cameron-Smith; Shikha Pundir
Journal:  Nutrients       Date:  2020-01-06       Impact factor: 5.717

Review 6.  Adiponectin as a Potential Biomarker for Pregnancy Disorders.

Authors:  Carmen Pheiffer; Stephanie Dias; Babalwa Jack; Nompumelelo Malaza; Sumaiya Adam
Journal:  Int J Mol Sci       Date:  2021-01-29       Impact factor: 5.923

7.  Inflammatory and Adipokine Status from Early to Midpregnancy in Arab Women and Its Associations with Gestational Diabetes Mellitus.

Authors:  Sara Al-Musharaf; Shaun Sabico; Syed Danish Hussain; Fatima Al-Tawashi; Haifa Bandar AlWaily; Nasser M Al-Daghri; Philip McTernan
Journal:  Dis Markers       Date:  2021-01-21       Impact factor: 3.434

8.  Placental and maternal sFlt1/PlGF expression in gestational diabetes mellitus.

Authors:  Anna Maria Nuzzo; Domenica Giuffrida; Laura Moretti; Paola Re; Giorgio Grassi; Guido Menato; Alessandro Rolfo
Journal:  Sci Rep       Date:  2021-01-27       Impact factor: 4.379

9.  Excessive Neutrophil Activity in Gestational Diabetes Mellitus: Could It Contribute to the Development of Preeclampsia?

Authors:  Lenka Vokalova; Shane V van Breda; Xi Lun Ye; Evelyn A Huhn; Nandor G Than; Paul Hasler; Olav Lapaire; Irene Hoesli; Simona W Rossi; Sinuhe Hahn
Journal:  Front Endocrinol (Lausanne)       Date:  2018-09-21       Impact factor: 5.555

Review 10.  Predictive and diagnostic biomarkers for gestational diabetes and its associated metabolic and cardiovascular diseases.

Authors:  A Lorenzo-Almorós; T Hang; C Peiró; L Soriano-Guillén; J Egido; J Tuñón; Ó Lorenzo
Journal:  Cardiovasc Diabetol       Date:  2019-10-30       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.